Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II intermittent letrozole plus transdermal estradiol gel as adjuvant endocrine therapy in postmenopausal hormone receptor–positive early breast cancer
2012-001978-28Phase 2Terminated
- Sponsor
- European Institute of Oncology
- Start
- Sep 2012
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of estradiol, letrozole in breast cancer, sponsored by European Institute of Oncology. Started Sep 2012; status: terminated.
02
Drugs
estradiolletrozole
03
Conditions
breast cancer
Beyond the preview
Go deeper on 2012-001978-28.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-001978-28.